Use of Dolutegravir for Treatment of HTLV-1
Clinical Infectious Diseases · 21.05.2026
DOI: 10.1093/cid/ciag324 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 21.05.2026. Verfasst von Carlos Brites und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, School of Medicine, Federal University of Bahia. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medicine, School of Medicine, Federal University of Bahia.
- Fundação Bahiana de Infectologia.
ORCID-Profile: Carlos Brites
Zitieren
APA
Brites, C., Montaño-Castellon, I., Marconi, C., Arriaga-Gutiérrez, M., Mayoral, R., Luz, E., & Netto, E. M. (2026). Use of Dolutegravir for Treatment of HTLV-1. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag324
Vancouver
Brites C, Montaño-Castellon I, Marconi C, Arriaga-Gutiérrez M, Mayoral R, Luz E, et al. Use of Dolutegravir for Treatment of HTLV-1. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag324
BibTeX
@article{Brites2026,
author = {Brites, Carlos and Montaño-Castellon, Iris and Marconi, Cleyde and Arriaga-Gutiérrez, María and Mayoral, Rafaela and Luz, Estela and Netto, Eduardo M},
title = {Use of Dolutegravir for Treatment of HTLV-1},
journal = {Clinical Infectious Diseases},
year = {2026},
doi = {10.1093/cid/ciag324}
}
EUVIMED